GoodRx Holdings (GDRX) Enterprise Value (2019 - 2025)
GoodRx Holdings (GDRX) has disclosed Enterprise Value for 7 consecutive years, with -$261.8 million as the latest value for Q4 2025.
- Quarterly Enterprise Value rose 41.6% to -$261.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$261.8 million through Dec 2025, up 41.6% year-over-year, with the annual reading at -$261.8 million for FY2025, 41.6% up from the prior year.
- Enterprise Value hit -$261.8 million in Q4 2025 for GoodRx Holdings, up from -$273.5 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$261.8 million in Q4 2025 to a low of -$993.4 million in Q1 2021.
- Historically, Enterprise Value has averaged -$642.1 million across 5 years, with a median of -$729.7 million in 2022.
- Biggest five-year swings in Enterprise Value: crashed 936.51% in 2021 and later skyrocketed 46.69% in 2024.
- Year by year, Enterprise Value stood at -$941.1 million in 2021, then increased by 19.55% to -$757.2 million in 2022, then rose by 11.21% to -$672.3 million in 2023, then skyrocketed by 33.31% to -$448.3 million in 2024, then skyrocketed by 41.6% to -$261.8 million in 2025.
- Business Quant data shows Enterprise Value for GDRX at -$261.8 million in Q4 2025, -$273.5 million in Q3 2025, and -$281.3 million in Q2 2025.